These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30239773)

  • 21. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid-modified manganese dioxide-enveloped hollow copper sulfide nanoparticles as a multifunctional system for the co-delivery of chemotherapeutic drugs and photosensitizers for efficient synergistic antitumor treatments.
    Li X; Pan Y; Zhou J; Yi G; He C; Zhao Z; Zhang Y
    J Colloid Interface Sci; 2022 Jan; 605():296-310. PubMed ID: 34329981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues.
    Huang HY; Chen LQ; Sun W; Du HH; Dong S; Ahmed AMQ; Cao D; Cui JH; Zhang Y; Cao QR
    Theranostics; 2021; 11(2):906-924. PubMed ID: 33391512
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycyrrhetinic acid remodels the tumor microenvironment and synergizes with doxorubicin for breast cancer treatment in a murine model.
    Tang M; Yang M; He K; Li R; Chen X; Wang Y; Zhang X; Qiu T
    Nanotechnology; 2021 Apr; 32(18):185702. PubMed ID: 33503591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
    Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
    Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversing Hypoxia with PLGA-Encapsulated Manganese Dioxide Nanoparticles Improves Natural Killer Cell Response to Tumor Spheroids.
    Murphy DA; Cheng H; Yang T; Yan X; Adjei IM
    Mol Pharm; 2021 Aug; 18(8):2935-2946. PubMed ID: 34191525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
    Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
    Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin.
    Wang YJ; Huang Y; Anreddy N; Zhang GN; Zhang YK; Xie M; Lin D; Yang DH; Zhang M; Chen ZS
    Oncotarget; 2016 Feb; 7(5):5877-91. PubMed ID: 26716507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer.
    Hu K; Zhang D; Ma W; Gu Y; Zhao J; Mu X
    Int J Nanomedicine; 2024; 19():6717-6730. PubMed ID: 38979530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of responsive "dual-lock" nanoparticles and their application in collaborative therapy based on CuS coordination.
    Jia C; Zhang M; He XW; Li WY; Zhang YK
    J Mater Chem B; 2021 Jan; 9(4):1049-1058. PubMed ID: 33399610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction.
    Zhang J; Zuo T; Yang J; Hu Z; Wang Z; Xu R; Ma S; Wei Y; Shen Q
    ACS Appl Mater Interfaces; 2021 Jan; 13(2):2256-2268. PubMed ID: 33423468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
    Wang C; Wei X; Shao G
    Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid manganese dioxide-bovine serum albumin nanostructure incorporated with doxorubicin and IR780 for enhanced breast cancer chemo-photothermal therapy.
    Yuan X; Yin Y; Zan W; Sun X; Yang Q
    Drug Deliv; 2019 Dec; 26(1):1254-1264. PubMed ID: 31760842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
    Feng X; Li F; Zhang L; Liu W; Wang X; Zhu R; Qiao ZA; Yu B; Yu X
    Acta Biomater; 2022 Apr; 143():392-405. PubMed ID: 35259519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
    Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
    J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.